Regen BioPharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
David Koos
Chief executive officer
US$10.1k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 3.7yrs |
| CEO ownership | 0.009% |
| Management average tenure | no data |
| Board average tenure | 9.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$867k |
| Jun 30 2024 | n/a | n/a | -US$883k |
| Mar 31 2024 | n/a | n/a | -US$840k |
| Dec 31 2023 | n/a | n/a | -US$775k |
| Sep 30 2023 | US$10k | US$10k | US$1m |
| Jun 30 2023 | n/a | n/a | US$1m |
| Mar 31 2023 | n/a | n/a | US$62m |
| Dec 31 2022 | n/a | n/a | US$1m |
| Sep 30 2022 | n/a | n/a | US$2m |
| Jun 30 2022 | n/a | n/a | US$910k |
| Mar 31 2022 | n/a | n/a | -US$67m |
| Dec 31 2021 | n/a | n/a | -US$6m |
| Sep 30 2021 | US$1 | n/a | -US$7m |
| Jun 30 2021 | n/a | n/a | -US$4m |
| Mar 31 2021 | n/a | n/a | US$6m |
| Dec 31 2020 | n/a | n/a | US$2m |
| Sep 30 2020 | n/a | n/a | US$3m |
| Jun 30 2020 | n/a | n/a | US$4m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | n/a | n/a | -US$454k |
| Sep 30 2019 | US$54k | US$54k | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$5m |
| Mar 31 2019 | n/a | n/a | -US$887k |
| Dec 31 2018 | n/a | n/a | -US$2m |
| Sep 30 2018 | US$180k | US$180k | -US$5m |
Compensation vs Market: David's total compensation ($USD10.05K) is below average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Koos (63 yo)
3.7yrs
Tenure
US$10,050
Compensation
Dr. David Raymond Koos, Ph D., DBA., served as Chairman of the Board of Directors, Chief Executive Officer, President, Secretary and Treasurer at SYBLEU INC. Dr. Koos serves as Chairman, CEO, President, Se...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 3.7yrs | US$10.05k | 0.0095% $ 99.6 | |
| Member of Scientific Advisory Board | 10.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 12.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 11.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.4yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.4yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.9yrs | no data | no data |
9.3yrs
Average Tenure
Experienced Board: RGBP's board of directors are considered experienced (9.3 years average tenure).